Drug production is pretty difficult. Pharma companies are high tech clean room manufacturers who operate at very high quality standards and large scale, with a significant amount of embedded knowledge and experience acquired over many years. The incredibly rapid roll out of Covid vaccines for example is testament to that.

Taking this into account, trying to develop sustainable and useful insulin production from scratch is 100% destined for failure, but good luck to them.